HB Wealth Management’s Gossamer Bio GOSS Stock Holding History

HB Wealth Management’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.71K	Buy	+16,451	New	+$4.59K	﹤0.01%	1717
2026 Q1	–	Sell	-95,924	Closed	-$297K	–	1572
2025 Q4	$297K	Buy	95,924 +1,176	+1%	+$3.36K	﹤0.01%	1142
2025 Q3	$249K	Buy	+94,748	New	+$209K	﹤0.01%	1166
2025 Q2	–	Sell	-46,700	Closed	-$51.4K	–	1217
2025 Q1	$51.4K	Buy	46,700 +9,000	+24%	+$10.4K	﹤0.01%	1194
2024 Q4	$33.2K	Buy	37,700 +10,200	+37%	+$8.74K	﹤0.01%	1050
2024 Q3	$27.1K	Buy	+27,500	New	+$26.5K	﹤0.01%	962

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

HB Wealth Management's GOSS Position: Q2 2026 in Review

HB Wealth Management opened a new position in Gossamer Bio (GOSS) in Q2 2026: 16,451 shares worth $2.71K. The stake represents ﹤0.01% of the portfolio and ranks #1717 among its holdings. This is a return to the name: HB Wealth Management previously reported a position in GOSS as recently as Q4 2025.

HB Wealth Management first reported a position in GOSS in Q3 2024 and has held it in 6 quarters since. The position peaked at $297K in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

HB Wealth Management held 16,451 shares of Gossamer Bio worth $2.71K as of Q2 2026.
Gossamer Bio was a new HB Wealth Management position in Q2 2026.
Gossamer Bio made up ﹤0.01% of HB Wealth Management's portfolio in Q2 2026, its #1717 holding.
HB Wealth Management first reported a position in Gossamer Bio in Q3 2024 and has held it in 6 quarters since.
HB Wealth Management's Gossamer Bio position peaked at $297K in Q4 2025.
170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.